Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Jonathan Jacobs
Introduction
Jonathan Jacobs is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant polypeptides. His work has implications for various applications in medicine and research.
Latest Patents
Jonathan Jacobs holds a patent for a method of producing a recombinant polypeptide in a mammalian cell culture. This method involves modifying the microRNA activity level in mammalian cells. Specifically, the patent discloses that the microRNA activity level can be either increased or decreased. In a more particular embodiment, the mammalian cells have a reduced miRNA-let-7a activity level. This innovative approach has the potential to enhance the efficiency of recombinant protein production.
Career Highlights
Jonathan Jacobs is currently employed at MedImmune Limited, a leading biotechnology company. His role at MedImmune allows him to work on cutting-edge research and development projects. With a focus on innovative solutions, he contributes to the advancement of therapeutic products.
Collaborations
Throughout his career, Jonathan has collaborated with talented individuals such as Katie Streicher and Robert W. Georgantas, III. These collaborations have fostered a dynamic research environment, leading to the development of impactful biotechnological solutions.
Conclusion
In summary, Jonathan Jacobs is a distinguished inventor whose work in recombinant polypeptide production showcases his innovative spirit and dedication to advancing biotechnology. His contributions continue to influence the field and pave the way for future discoveries.